Milestone Scientific Inc (MLSS)
AMEXHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
$0.47+0.06%
Close 2026-09-04 · 1-day change
AMEXHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · MLSS
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance dropped from the top half to the bottom half of its industry over the past month — the reason to own it has weakened.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -48.4% |
| Our one-year growth estimate | diamond | 15.1% |
Growth built into the price is above our model estimate.
The price assumes 63.5 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Model as of 2026-09-04 · Compared with 26 industry peers · Company calendar date is not available
MLSS — private placement
Dated 2026-07-29
Other Events On July 24, 2026, Milestone Scientific Inc. (the “Company”) received notices of conversion (the “Conversion Notices”) from Benedetta Casamento, Dr. Didier Demesmin and Neal Goldman, each of whom is a director of the Company (collectively, the “Holders”), with respect to the Company’s amended and restated promissory notes held by the Holders (the “Convertible Bridge Notes”). As previously disclosed, the Convertible Bridge Notes were originally issued in an aggregate principal amou…
Why it matters: This funding aims to support growth. Its effectiveness will show how well the company can scale operations.
Supportive ifPositive revenue growth or expansion in product offerings linked to the use of the funds.
Worry ifNo growth or more capacity despite the funding.
Why it matters: This financing aims to strengthen the balance sheet and support growth. It shows investor confidence in the company's direction.
Supportive ifThe company says it sold all units in the private placement.
Worry ifThe company says the private placement did not raise enough funds. There was a big pullback from investors.
Why it matters: New experienced directors may improve governance. They can help Milestone grow. Their work will be important for future success.
Supportive ifThe company shows better results or new plans after the board changes.
Worry ifThere is no clear change in results or plans after the board changes.
Why it matters: Better cash flow is important for the company's finances. Changing cash flow shows ongoing problems.
Watch forCash flow from operations grows steadily for two quarters in a row.
Also watch forCash flow from operations drops again or stays negative for two quarters.
Why it matters: The company adds experienced directors to help with strategy and governance. They could help future growth.
Supportive ifThe company sees better strategy and revenue growth after the board changes.
Worry ifThe company has governance problems or slow growth even after the board changes.
Why it matters: Better cash flow is key for the company's finances. Unstable cash flow may show ongoing problems.
Watch forCash flow from operations is getting better. This shows improved management.
Also watch forCash flow from operations is still going down or is negative.
Why it matters: M&A activities could enhance growth and market position. Progress in this area is crucial for future expansion.
Supportive ifThe company announces a new partnership or acquisition. This will help its market reach and product range.
Worry ifThe company reports setbacks or delays in M&A activities that hinder growth plans.
Why it matters: If the shares convert at $0.50 or more, it shows confidence in the stock's value. This could support Milestone's financial stability.
Supportive ifNotice of conversion of the promissory notes occurs when shares reach $0.50 or more.
Worry ifShares are below $0.50. This means no conversions and possible cash issues.
Why it matters: Continued revenue growth signals that Milestone's strategies are working. It could attract more investors.
Supportive ifQ3 revenue exceeds $2.84 million, showing continued growth from Q2.
Worry ifQ3 revenue is below $2.84 million. This shows possible problems with growth plans.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$325 on $10,000 · ±3.2% | How much price usually moves either way. |
| Bad day | $839 loss on $10,000 · 8.4% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $6,132 loss on $10,000 · 61.3% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.